Smilow Cancer Hospital at Yale New Haven — New Haven, Connecticut

Smilow Cancer Hospital at Yale New Haven is a clinical research site located in New Haven, Connecticut, United States 06511.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Smilow Cancer Hospital at Yale New Haven has participated in 32 clinical trials with 13 currently active.

Therapeutic areas: AML, AML With Mutated NPM1, Hematologic Malignancy.

Sponsors: Kura Oncology, Inc., Hoffmann-La Roche, Eikon Therapeutics.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Smilow Cancer Hospital at Yale New Haven?

Smilow Cancer Hospital at Yale New Haven has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Smilow Cancer Hospital at Yale New Haven conducted?

Smilow Cancer Hospital at Yale New Haven has 32 clinical trials on record, with 13 currently active. Their work covers AML, AML With Mutated NPM1, Hematologic Malignancy.

Is Smilow Cancer Hospital at Yale New Haven accredited by Crixeo Health?

Yes — Smilow Cancer Hospital at Yale New Haven holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Smilow Cancer Hospital at Yale New Haven?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.